Department of Oncology, University of Turin, Candiolo, Italy.
EMBO Mol Med. 2012 Nov;4(11):1156-75. doi: 10.1002/emmm.201101164. Epub 2012 Oct 16.
Homing of colorectal cancer (CRC) cells to the liver is a non-random process driven by a crosstalk between tumour cells and components of the host tissue. Here we report the isolation of a liver metastasis-specific peptide ligand (CGIYRLRSC) that binds a complex of E-cadherin and α(6) integrin on the surface of CRC cells. We identify angiopoietin-like 6 protein as a peptide-mimicked natural ligand enriched in hepatic blood vessels of CRC patients. We demonstrate that an interaction between hepatic angiopoietin-like 6 and tumoural α(6) integrin/E-cadherin drives liver homing and colonization by CRC cells, and that CGIYRLRSC inhibits liver metastasis through interference with this ligand/receptor system. Our results indicate a mechanism for metastasis whereby a soluble factor accumulated in normal vessels functions as a specific ligand for circulating cancer cells. Consistently, we show that high amounts of coexpressed α(6) integrin and E-cadherin in primary tumours represent a poor prognostic factor for patients with advanced CRC.
结直肠癌(CRC)细胞向肝脏的归巢是一个非随机的过程,由肿瘤细胞与宿主组织成分之间的串扰驱动。在这里,我们报告了一种肝转移特异性肽配体(CGIYRLRSC)的分离,该配体结合 CRC 细胞表面的 E-钙黏蛋白和α(6)整合素复合物。我们鉴定出血管生成素样蛋白 6 蛋白作为一种富含 CRC 患者肝血管的肽模拟天然配体。我们证明,肝血管生成素样蛋白 6 与肿瘤性α(6)整合素/E-钙黏蛋白之间的相互作用驱动 CRC 细胞向肝脏归巢和定植,而 CGIYRLRSC 通过干扰该配体/受体系统抑制肝转移。我们的结果表明了一种转移机制,即正常血管中积累的可溶性因子作为循环癌细胞的特异性配体发挥作用。一致地,我们表明,原发肿瘤中大量共表达的α(6)整合素和 E-钙黏蛋白是晚期 CRC 患者预后不良的一个因素。